Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
Appointed director
HALOZYME THERAPEUTICS, INC. (HALO) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/09/2023 SC 13G/A VANGUARD GROUP INC reports a 10.3% stake in Halozyme Therapeutics Inc.
02/10/2023 SC 13G/A BlackRock Inc. reports a 14.2% stake in HALOZYME THERAPEUTICS INC
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 9.8% stake in Halozyme Therapeutics Inc.
01/26/2023 SC 13G/A BlackRock Inc. reports a 13.6% stake in HALOZYME THERAPEUTICS INC
12/12/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2022 SC 13G/A VANGUARD GROUP INC reports a 9.6% stake in Halozyme Therapeutics Inc.
02/04/2022 SC 13G/A Artisan Partners Limited Partnership reports a 6.8% stake in Halozyme Therapeutics, Inc.
01/28/2022 SC 13G/A BlackRock Inc. reports a 13.8% stake in HALOZYME THERAPEUTICS INC
02/12/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2021 SC 13G/A Artisan Partners Limited Partnership reports a 7.6% stake in Halozyme Therapeutics, Inc.
01/26/2021 SC 13G/A BlackRock Inc. reports a 13.7% stake in HALOZYME THERAPEUTICS INC
02/14/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/28/2020 SC 13G/A Iridian Asset Management reports a 0% stake in Halozyme Therapeutics, Inc.
02/13/2019 SC 13G/A BB BIOTECH AG reports a 5.8% stake in HALOZYME THERAPEUTICS, INC.
02/11/2019 SC 13G/A VANGUARD GROUP INC reports a 9.3% stake in Halozyme Therapeutics Inc
02/06/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/04/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/06/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/05/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/25/2018 SC 13G/A BlackRock Inc. reports a 8.5% stake in HALOZYME THERAPEUTICS INC
02/14/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
02/13/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
02/02/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
01/23/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
02/11/2016 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
02/14/2012 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy